News
Shorter Antiplatelet Tx After Stenting Safe
- Author:
- Caroline Helwick
Publish date: June 1, 2011
News
Factors Predict Successful Weaning From VAD
- Author:
- Caroline Helwick
Publish date: May 15, 2011
News
Factors Predict Successful Weaning From VAD
- Author:
- Caroline Helwick
Publish date: May 15, 2011
News
BRAF Mutation Status May Change Papillary Thyroid Cancer Management
- Author:
- Caroline Helwick
Publish date: May 11, 2011
News
BRAF Mutation Status May Change Papillary Thyroid Cancer Management
- Author:
- Caroline Helwick
Publish date: May 11, 2011
News
PRECOMBAT: Use PCI for Select Left Main Disease?
- Author:
- Caroline Helwick
Publish date: May 1, 2011
Major Finding: At 2 years, the composite of death, myocardial infarction and stroke was 4.4% in the PCI group and 4.7% in the CABG group.
News
Benefits of Lipid-Lowering Agents Persists After Trials End
- Author:
- Caroline Helwick
Publish date: May 1, 2011
News
ApoB Synthesis Inhibitor Cut LDL Cholesterol
- Author:
- Caroline Helwick
Publish date: May 1, 2011
News
Taking Ambulance Cuts Time to Cath Lab 26%
- Author:
- Caroline Helwick
Publish date: May 1, 2011
News
EVEREST II: 2-Year Data Show MitraClip Safety : Although percutaneous repair is safer than surgery, it does not reduce mitral regurgitation as completely.
- Author:
- Caroline Helwick
Publish date: May 1, 2011
News
Benefits of Using Lipid-Lowering Agents Persist After Trials End
- Author:
- Caroline Helwick
Publish date: April 22, 2011
Major Finding: During the open-label phase of randomized trials studied, the lower mortality among those who initially received active therapy...
News
Benefits of Using Lipid-Lowering Agents Persist After Trials End
- Author:
- Caroline Helwick
Publish date: April 22, 2011
Major Finding: During the open-label phase of randomized trials studied, the lower mortality among those who initially received active therapy...
News
Shorter Antiplatelet Therapy Course After Stenting May Be Acceptable
- Author:
- Caroline Helwick
Publish date: April 13, 2011
Major Finding: The rates of 12-month target vessel failure were 4.7% for drug-eluting stent recipients given 6-months of clopidogrel and aspirin...
News
ARB, CCB Both Help Prevent Events in Hypertensive Diabetes Patients
- Author:
- Caroline Helwick
Publish date: April 6, 2011
Major Finding: At 3.2 years, cardiovascular events were observed in 54 (9.4%) patients in the valsartan group and 56 (9.7%) in the amlodipine...
News
ARB, CCB Both Help Prevent Events in Hypertensive Diabetes Patients
- Author:
- Caroline Helwick
Publish date: April 6, 2011